RxRegimen check replace synthesize
Back to Library
FDA LABEL GENERIC: Camphor MFR: A-S Medication Solutions

Camphor 0.03 Mg/mg / Dimethicone 0.03 Mg/mg / Lidocaine 0.04 Mg/mg / Menthol 0.01 Mg/mg Topical Gel

Methemoglobinemia

Cases of methemoglobinemia have been reported in association with local anesthetic use. Although all patients are at risk for methemoglobinemia, patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants under 6 months of age, and concurrent exposure to oxidizing agents or their metabolites are more susceptible to developing clinical manifestations of the condition. If local anesthetics must be used in these patients, close monitoring for symptoms and signs of methemoglobinemia is recommended.

Signs and symptoms of methemoglobinemia may occur immediately or may be delayed some hours after exposure and are characterized by a cyanotic skin discoloration and abnormal coloration of the blood. Methemoglobin levels may continue to rise; therefore, immediate treatment is required to avert more serious central nervous system and cardiovascular adverse effects, including seizures, coma, arrhythmias, and death. Discontinue lidocaine-containing products and any other oxidizing agents. Depending on the severity of the symptoms, patients may respond to supportive care, i.e., oxygen therapy, hydration. More severe symptoms may require treatment with methylene blue, exchange transfusion, or hyperbaric oxygen

Lidocaine 4%

Topical Anesthetic

Menthol 1%

Topical Analgesic

Camphor 3%

Topical Analgesic

Dimethicone 3%

Skin Conditioner

INDICATIONS AND USAGE

For the temporary relief of joint pain and muscle pain associated with:

Arthritis Backache Discomfort Cramps Neckache Soreness Sprains Strains

WARNINGS

For External Use Only

Keep away from excessive heat or open flame

On damaged or irritated skin With a bandage or heating pad If you are allergic to any ingredients in this product Other than as directed

Avoid contact with the eyes

Condition worsens Excessive skin irritation develops Symptoms persist for more than 7 days, or symptoms clear up and occur again within 3 days

Ask a health professional before use

If ingested, seek medical help or contact a Poison Control Center immediately

DOSAGE AND ADMINISTRATION

Ad ults and Children 12 years of Age and Older:

Clean and dry the affected area Apply product directly to your skin, up to 4 times daily
Store in a cool, dry place with lid tightly closed

Aloe Barbadensis Leaf Juice, Arnica Montana Flower, Boswellia Serrata Extract, Carbomer, Ethylhexylglycerin, FD&C Blue #1, Methylsulfonylmethane, Phenoxyethanol, Polysorbate 20, SD-Alcohol 40B, Sorbitol, Triethanolamine, Water.

(877) 985-8377

HOW SUPPLIED

Product: 50090-4640

NDC: 50090-4640-0 89 mL in a TUBE, WITH APPLICATOR

Lidocaine, Menthol, Camphor, and Dimethicone Gel